Biocryst Pharmaceuticals (BCRX) EBT Margin Growth (1y) (2011 - 2026)
Biocryst Pharmaceuticals (BCRX) EBT Margin Growth (1y) (2011 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin Growth (1y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 87.22 Bn | 85.35 Bn | - | - |
| 2 | Teva Pharmaceutical Industries | 39.60 Bn | 35.87 Bn | 1.97 Bn | 342.00 |
| 3 | Zoetis | 31.46 Bn | 29.52 Bn | 1.62 Bn | -166.00 |
| 4 | Takeda Pharmaceutical | 26.49 Bn | 22.44 Bn | 4.39 Bn | -5,404.00 |
| 5 | United Therapeutics | 23.03 Bn | 20.88 Bn | 648.10 Mn | -1,258.00 |
| 6 | Universe Pharmaceuticals | 23.03 Bn | -10.56 Bn | - | - |
| 7 | Viatris | 20.90 Bn | 19.09 Bn | 1.16 Bn | 8,812.00 |
| 8 | Neurocrine Biosciences | 17.50 Bn | 16.19 Bn | 800.70 Mn | 2,773.00 |
| 9 | Elanco Animal Health | 12.33 Bn | 11.91 Bn | 785.00 Mn | 132.00 |
| 10 | Biocryst Pharmaceuticals | 2.27 Bn | 2.20 Bn | 151.04 Mn | -46,136.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -46,136.00 |
| Dec 31, 2025 | 3.51 Mn |
| Sep 30, 2025 | 1,909.00 |
| Jun 30, 2025 | 1,541.00 |
| Mar 31, 2025 | 3,827.00 |
| Dec 31, 2024 | 4,786.00 |
| Sep 30, 2024 | 2,981.00 |
| Jun 30, 2024 | 7,898.00 |
| Mar 31, 2024 | 3,882.00 |
| Dec 31, 2023 | 2,222.00 |
| Sep 30, 2023 | 1,277.00 |
| Jun 30, 2023 | -191.00 |
| Mar 31, 2023 | 7,149.00 |
| Dec 31, 2022 | -5,692.00 |
| Sep 30, 2022 | 8,937.00 |
| Jun 30, 2022 | -204.00 |
| Mar 31, 2022 | 18,923.00 |
| Dec 31, 2021 | 163,396.00 |
| Sep 30, 2021 | 61,210.00 |
| Jun 30, 2021 | 126,045.00 |